These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33350787)

  • 1. ASF (a Compound of Traditional Chinese Medicine) in the treatment of patients with alcohol dependence: Study protocol of a randomized, double-blinded, placebo-controlled clinical trial.
    Liang X; Hu X; Zhang X; Fu H
    Medicine (Baltimore); 2020 Dec; 99(52):e23899. PubMed ID: 33350787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial.
    Antonsen KK; Klausen MK; Brunchmann AS; le Dous N; Jensen ME; Miskowiak KW; Fisher PM; Thomsen GK; Rindom H; Fahmy TP; Vollstaedt-Klein S; Benveniste H; Volkow ND; Becker U; Ekstrøm C; Knudsen GM; Vilsbøll T; Fink-Jensen A
    BMJ Open; 2018 Jul; 8(7):e019562. PubMed ID: 30012779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Traditional Chinese Medicine, Maxingshigan-Weijing in the management of COVID-19 patients with severe acute respiratory syndrome: A structured summary of a study protocol for a randomized controlled trial.
    Zeng C; Yuan Z; Pan X; Zhang J; Zhu J; Zhou F; Shan Z; Yuan Y; Ye R; Cheng J
    Trials; 2020 Dec; 21(1):1029. PubMed ID: 33357239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of YinQiSanHuang-antiviral decoction in chronic hepatitis B: study protocol for a randomized, placebo-controlled, double-blinded trial.
    Wu QJ; Lv WL; Li JM; Zhang TT; Zhou WH; Zhang Q; Wang JC; Wang QN; Zhang RX; Zhao X; Chen ST; Liu S; Li GH; Cao ZM; Xu L; Chen J
    Trials; 2020 Jun; 21(1):482. PubMed ID: 32503608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial.
    McAndrew A; Lawn W; Stevens T; Porffy L; Brandner B; Morgan CJ
    Trials; 2017 Apr; 18(1):159. PubMed ID: 28372596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
    Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
    Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of umbilical therapy with the traditional Chinese medicine formulation Lishui Xiaogu cataplasm for cirrhotic ascites: protocol for a randomized controlled trial.
    Yang X; Ru S; Luo L; Lv X; Bai W; Zhang F; Jiang F
    Trials; 2019 Feb; 20(1):127. PubMed ID: 30760320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Sweet-Liking Phenotype and Craving for Alcohol With the Response to Naltrexone Treatment in Alcohol Dependence: A Randomized Clinical Trial.
    Garbutt JC; Kampov-Polevoy AB; Kalka-Juhl LS; Gallop RJ
    JAMA Psychiatry; 2016 Oct; 73(10):1056-1063. PubMed ID: 27627782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence.
    Kampman KM; Pettinati HM; Lynch KG; Spratt K; Wierzbicki MR; O'Brien CP
    Drug Alcohol Depend; 2013 Nov; 133(1):94-9. PubMed ID: 23810644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prefrontal Cortex Transcranial Direct Current Stimulation Treatment in Alcohol Dependence Syndrome (PreCoTTA): Study Protocol for a Double- blind Randomized Sham-controlled Trial.
    Deshmukh AS; Praharaj SK; Rai S; Kamath A; Upadhya D
    Rev Recent Clin Trials; 2021; 16(4):409-420. PubMed ID: 34365959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
    Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
    Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of transcranial direct current stimulation (tDCS) in reducing consumption in patients with alcohol use disorders: study protocol for a randomized controlled trial.
    Trojak B; Soudry-Faure A; Abello N; Carpentier M; Jonval L; Allard C; Sabsevari F; Blaise E; Ponavoy E; Bonin B; Meille V; Chauvet-Gelinier JC
    Trials; 2016 May; 17(1):250. PubMed ID: 27188795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin treatment for alcohol dependence: a randomized clinical trial.
    Mason BJ; Quello S; Goodell V; Shadan F; Kyle M; Begovic A
    JAMA Intern Med; 2014 Jan; 174(1):70-7. PubMed ID: 24190578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial.
    Furieri FA; Nakamura-Palacios EM
    J Clin Psychiatry; 2007 Nov; 68(11):1691-700. PubMed ID: 18052562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.
    Simioni N; Labreuche J; Behal H; Cottencin O; Rolland B
    J Clin Psychopharmacol; 2017 Dec; 37(6):722-728. PubMed ID: 28984747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study.
    Wetzel L; Pourbaix M; Riegler A; Pfeifer AM; Reinhard I; Hoffmann S; Vollstädt-Klein S; Kiefer F; Sommer W; Bumb JM; Bach P; Koopmann A
    Trials; 2022 Aug; 23(1):693. PubMed ID: 35986409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled trial of quetiapine in patients with bipolar disorder, mixed or depressed phase, and alcohol dependence.
    Brown ES; Davila D; Nakamura A; Carmody TJ; Rush AJ; Lo A; Holmes T; Adinoff B; Caetano R; Swann AC; Sunderajan P; Bret ME
    Alcohol Clin Exp Res; 2014 Jul; 38(7):2113-8. PubMed ID: 24976394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ON-ICE trial: Investigation of the combined effects of oxytocin and naltrexone on stress-induced and alcohol cue-induced craving in alcohol use disorder-Study protocol of a phase II randomised double-blind placebo-controlled parallel-group trial.
    Zimmermann S; Thomas BC; Krisam J; Limprecht R; Klose C; Stenger M; Pourbaix M; Ries M; Vollstaedt-Klein S; Koopmann A; Lenz B; Kiefer F; Bach P
    BMJ Open; 2022 Apr; 12(4):e059672. PubMed ID: 35410938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.